Avery Dennison Corporation
—- Market cap
- —
- Debt
- —
- Cash
- −$202.80M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: AVY stock price vs LLY: inconclusive — current versus $427.32 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LLY's multiple
Implied fair value · at AVY's multiple
Needs AVY P/E.
Snapshot Sep 11, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 96% equity / 4% debt · EV / Revenue 16.65x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AVERY DENNISON CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ELI LILLY AND COMPANY · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
3M CO
AVY vs MMM
EASTMAN CHEMICAL CO
AVY vs EMN
ILLINOIS TOOL WORKS INC
AVY vs ITW
RPM INTERNATIONAL INC/DE/
AVY vs RPM
BRADY CORP
AVY vs BRC
METTLER TOLEDO INTERNATIONAL INC/
AVY vs MTD
Pfizer Inc.
AVY vs PFE
Merck & Co., Inc.
AVY vs MRK
Johnson & Johnson
AVY vs JNJ
AbbVie Inc.
AVY vs ABBV
Amgen Inc.
AVY vs AMGN
Bristol-Myers Squibb Company
AVY vs BMY
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.